United States women’s national team goalie Hope Solo received a public warning from the United State Anti-Doping Agency after testing positive for the diuretic Canrenone, according to a media release by USADA. Solo said she was taking the medication under the care of her doctors, according to the release.
Solo will still play in this summer’s Olympics.
“I took a medication prescribed by my personal doctor for pre-menstrual purposes that I did not know contained a diuretic,” Solo said, according to the news release. “Once informed of this fact, I immediately cooperated with USADA and shared with them everything they needed to properly conclude that I made an honest mistake, and that the medication did not enhance my performance in any way. As someone who believes in clean sport, I am glad to have worked with USADA to resolve this matter and I look forward to representing my country at the 2012 Olympic Games in London.”
Canrenone is not a performance-enhancing drug but is still banned under “USADA Protocol for Olympic and Paralympic Movement Testing and the International Federation of Association Football (FIFA) anti-doping rules.”
The positive test stemmed from a urine sample Solo gave on June 15, the day before a match with Sweden.